Skip to content

Released Nov 1, 2023, after the close

10-Q filed Nov 2, 2023, 33 days after period end · 0001653477-23-000057

Q3 2023 · 10-Q
Revenue$446.00M−7.5% vs Q3 2022−7.4% vs Q2 2023
Net Income$25.20M−66.6% vs Q3 2022−29.0% vs Q2 2023
EPS Diluted$0.69−65.2% vs Q3 2022−28.9% vs Q2 2023
Gross Profit$129,000,000−26.8%
Operating Income$110,400,000−20.1%
Operating Cash Flowderived$105,200,000+5.1%
Free Cash Flowderived$71,700,000+12.0%
Margins · derived
Gross margin28.9%−7.7 pt vs Q3 2022
Operating margin24.8%−3.9 pt vs Q3 2022
Net margin5.7%−10.0 pt vs Q3 2022

What the release said

The release

Same quarter

MetricQ3 2023Q3 2022Q3 2021Q3 2020
Revenue$446.00M$482.00M$376.80M$331.70M
Net Income$25.20M$75.40M-$4.20M$69.90M
EPS Diluted$0.69$1.98-$0.11$1.69

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR